AZN Astrazeneca Plc

12,106.00

-20.00 (-0.16%)

19 Jul 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Astrazeneca Plc	LSE:AZN	London	Ordinary Share	GB0009895292	ORD SHS $0.25

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	-20.00	-0.16%	12,106.00	12,120.00	12,122.00	12,190.00	12,024.00	12,080.00	999,558	16:35:02

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Pharmaceutical Preparations	45.81B	5.96B	3.8415	31.55	187.98B

Seroquel Approvable Letter

30/10/2003 1:00pm

UK Regulatory

RNS Number:4850R
AstraZeneca PLC
30 October 2003


Stock Exchange Announcement


ASTRAZENECA RECEIVES FDA APPROVABLE LETTER FOR SEROQUELTM (QUETIAPINE FUMARATE)
                                    TABLETS
                              IN TREATMENT OF MANIA


AstraZeneca today announced that it has received an approvable letter from the
U.S. Food and Drug Administration (FDA) in response to its Supplemental New Drug
Applications (sNDAs) for the use of SEROQUEL as both an adjunct and monotherapy
for the treatment of manic episodes associated with bipolar disorder.  The
company is working closely with the FDA to supply information and to finalize
labelling.


                                     -Ends-

30th October, 2003



Media Enquiries:
Chris Major, +44 (0) 207 304 5028


Investor Enquiries:

Mina Blair-Robinson, +44 (0) 207 304 5084
Jonathan Hunt, +44 (0) 207 304 5087


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

REAURVAROWRROAA